BackRevelation Biosciences- Warrants(10/01/2027) Overview

Revelation Biosciences- Warrants(10/01/2027) Total Liabilities

Latest total liabilities for REVBW: $2.1M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$2.06M
↑ 88.65% YoYΔ $965810.00 vs prior year quarter

Peer average

Loading

Revelation Biosciences- Warrants(10/01/2027) Total Liabilities History

Loading

Revelation Biosciences- Warrants(10/01/2027) vs. peers: Total Liabilities Comparison

Loading

Revelation Biosciences- Warrants(10/01/2027) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Revelation Biosciences- Warrants(10/01/2027) (REVBW) FAQ

As of the most recent data (March 2026), REVBW shows a total liabilities of $2.1M. That compares with $1.1M in the prior-year period — up 88.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REVBW's total liabilities is now $2.1M (was $1.1M) — a 88.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Revelation Biosciences- Warrants(10/01/2027) is outperforming or lagging.

Tracking REVBW's total liabilities over time shows whether Revelation Biosciences- Warrants(10/01/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.1M That compares with $1.1M in the prior-year period — up 88.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Revelation Biosciences- Warrants(10/01/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $2.1M) with ownership activity and broader fundamentals.